More articles from Conference Proceeding - Introduction

You have access
Role of Risk Assessments in Viral Safety: An FDA Perspective
Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann

PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959
You have access
Viral Safety Perspective from the Paul-Ehrlich-Institut in Europe
Johannes Blümel

PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 11-12; DOI: https://doi.org/10.5731/pdajpst.2014.00960
You have access
Overview of 2009 Indianapolis Conference White Paper: The Goal of an Integrated Viral Clearance Strategy
Kurt Brorson

PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 2-5; DOI: https://doi.org/10.5731/pdajpst.2014.00958

Main menu